Jyong Biotech Ltd. (MENS)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	608.22M
Revenue (ttm)	n/a
Net Income (ttm)	-4.40M
Shares Out	76.03M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About MENS

Jyong Biotech is a science-driven biotechnology company based in Taiwan and is committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia (primarily Taiwan and mainland China). Among our drug candidates, we have filed the new drug application in the US, for MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms. PCP, our key new drug candidate dev...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 31
• Stock Exchange: NASDAQ
• Ticker Symbol: MENS
• Website: https://www.healtheverbiotech.com/

Financial Performance

Financial numbers in USD